NCT05108922 · Interventional trial
A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)
Overall registry status Completed
Phase 3
Conditions Alzheimer Disease, Mild Cognitive Impairment (MCI)
Delaware Valley sites
- Abington Neurological Associates, Ltd. · Abington, PA · Montgomery County
- The Clinical Trial Center, LLC · Jenkintown, PA · Montgomery County
First posted
Registry updated
Added to the directory